Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AKER

Akers Biosciences (AKER)

Akers Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AKER
DateTimeSourceHeadlineSymbolCompany
05/14/20201:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
05/14/20201:00PMGlobeNewswire Inc.Akers Biosciences Announces $4.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq RulesNASDAQ:AKERAkers Biosciences Inc
05/14/20209:33AMGlobeNewswire Inc.Akers Biosciences and Premas Biotech Announce Successful Completion of Vaccine Prototype & Obtained First Images of VLPNASDAQ:AKERAkers Biosciences Inc
05/05/20202:16PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AKERAkers Biosciences Inc
04/20/202011:48AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AKERAkers Biosciences Inc
04/17/20204:16PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:AKERAkers Biosciences Inc
04/17/20204:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
04/14/20202:29PMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:AKERAkers Biosciences Inc
04/14/20209:21AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
04/08/20209:25AMGlobeNewswire Inc.Akers Biosciences and Premas Biotech Announce Successful Expression of Coronavirus AntigensNASDAQ:AKERAkers Biosciences Inc
04/08/20209:17AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AKERAkers Biosciences Inc
04/08/20206:21AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
04/08/20206:00AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AKERAkers Biosciences Inc
04/07/20205:11PMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:AKERAkers Biosciences Inc
04/07/202010:53AMGlobeNewswire Inc.Akers Biosciences Announces $4.6 Million Registered Direct Offering Priced At-the-Market under Nasdaq RulesNASDAQ:AKERAkers Biosciences Inc
04/07/202010:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
04/07/20206:03AMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:AKERAkers Biosciences Inc
04/06/20209:25AMGlobeNewswire Inc.Akers Biosciences and Premas Biotech Announce Progress in its Vaccine Development for Covid-19NASDAQ:AKERAkers Biosciences Inc
03/25/20206:01AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:AKERAkers Biosciences Inc
03/24/20204:06PMGlobeNewswire Inc.Akers Biosciences Schedules Conference Call to Discuss Licensing Announcement with Premas Biotech for a Coronvirus Vaccine Ca...NASDAQ:AKERAkers Biosciences Inc
03/24/20209:22AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
03/24/20209:00AMGlobeNewswire Inc.Akers Biosciences Acquires Licenses to Coronavirus Vaccine Candidate from Premas BiotechNASDAQ:AKERAkers Biosciences Inc
03/03/20202:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AKERAkers Biosciences Inc
02/27/20204:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AKERAkers Biosciences Inc
01/17/20205:00PMGlobeNewswire Inc.Akers Biosciences, Inc. Provides Notice of Proposed Settlement of Derivative LitigationNASDAQ:AKERAkers Biosciences Inc
12/11/20199:30AMGlobeNewswire Inc.Akers BioSciences Regains Compliance with Nasdaq Listing StandardsNASDAQ:AKERAkers Biosciences Inc
12/09/201911:40AMGlobeNewswire Inc.Akers BioSciences, Inc. Announces Closing of Approximately $8 Million Public OfferingNASDAQ:AKERAkers Biosciences Inc
12/06/20199:30AMGlobeNewswire Inc.Akers Biosciences to Attend Hemp Industry Daily Forum in Las Vegas, NevadaNASDAQ:AKERAkers Biosciences Inc
12/05/20199:25AMGlobeNewswire Inc.Akers BioSciences, Inc. Announces Pricing of Approximately $8 Million Public OfferingNASDAQ:AKERAkers Biosciences Inc
12/05/20198:45AMGlobeNewswire Inc.Akers Biosciences Continues Strategic Review; Explores Leveraging its 30-years of Laboratory Operations to Enter into the Hem...NASDAQ:AKERAkers Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:AKER